Facetten
Zugriff
Einrichtung
Medientyp
- Text 7
Karte
Erscheinungsjahr
Autor/in
- Augustin, Doris
- Briest, Susanne 5
- Ettl, Johannes 5
- Haidinger, Renate 5
- Lüftner, Diana 5
- alle zeigen
Sprache
7 Einträge gefunden
-
Impact of RNA signatures on pCR and survival after 12-week neoadjuvant pertuzumab plus trastuzumab with or without paclitaxel in the WSG-ADAPT-HER2+/HR- trial
- Graeser, Monika
- Gluz, Oleg
- Biehl, Claudia
- Ulbrich-Gebauer, Daniel
- Christgen, Matthias
- Palatty, Jenci
- Kuemmel, Sherko
-
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial
- Nitz, Ulrike
- Gluz, Oleg
- Graeser, Monika
- Christgen, Matthias
- Kuemmel, Sherko
- Grischke, Eva-Maria
- Braun, Michael
-
-
ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019:Commentary by the German panel of experts on the ABC5 voting results
- Untch, Michael
- Würstlein, Rachel
- Lüftner, Diana
- Haidinger, Renate
- Fasching, Peter A
- Augustin, Doris
- Briest, Susanne
-
4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017: ABC4 Consensus: Assessment by a Panel of German Experts
- Untch, Michael
- Würstlein, Rachel
- Marschner, Norbert
- Lüftner, Diana
- Augustin, Doris
- Briest, Susanne
- Ettl, Johannes
-
ABC4 Consensus: Assessment by a German Group of Experts
- Harbeck, Nadia
- Lüftner, Diana
- Marschner, Norbert
- Untch, Michael
- Augustin, Doris
- Briest, Susanne
- Ettl, Johannes
-
ABC4-Konsensus: Bewertung durch eine deutsche Expertengruppe:4. Internationale Konsensuskonferenz zum fortgeschrittenen Mammakarzinom (ABC4), Lissabon, 04. 11. 2017
- Würstlein, Rachel
- Harbeck, Nadia
- Thomssen, Christoph
- Lüftner, Diana
- Augustin, Doris
- Briest, Susanne
- Ettl, Johannes